Annual Drug Patent Expirations for RIOMET
Riomet is a drug marketed by Ranbaxy and Sun Pharm and is included in two NDAs. It is available from one supplier. There are two patents protecting this drug and one Paragraph IV challenge.
Drug patent litigation for RIOMET.
This drug has eighteen patent family members in eighteen countries.
The generic ingredient in RIOMET is metformin hydrochloride. One supplier is listed for this compound. Additional details are available on the metformin hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com